Cabaletta Bio (CABA) Downgraded by Zacks Investment Research to Hold

Cabaletta Bio} stock has undergone multiple analysts rating changes in the recent past.  Cabaletta Bio Downgraded by Zacks Investment Research on 10/11/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Cabaletta Bio (CABA) Downgraded by Zacks Investment Research to Hold